ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,547Medicare Part D Prescriptions Filled, Including Refills

Rank: 137 out of 2429

$673K Total Retail Price of All Prescriptions

Rank: 140 out of 2429

635 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 635 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

10% of this provider’s 635 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

3% of this provider’s 10,428 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LISINOPRIL 708 634 1 2
SIMVASTATIN 520 429 2 1
LEVOTHYROXINE SODIUM 435 366 3 3
INDAPAMIDE 397 341 4 184
AMLODIPINE BESYLATE 333 272 5 4
HYDROCODONE-ACETAMINOPHEN 320 191 S3 6 6
METOPROLOL TARTRATE 305 279 7 9
GLIMEPIRIDE 277 269 8 51
ATORVASTATIN CALCIUM 220 181 9 13
ZOLPIDEM TARTRATE 217 191 10 28
PANTOPRAZOLE SODIUM 192 177 11 34
METFORMIN HCL ER 181 151 12 65
OMEPRAZOLE 180 132 13 7
RANITIDINE HCL 179 142 14 24
FUROSEMIDE 170 157 15 5
ALLOPURINOL 160 122 16 33
METOPROLOL SUCCINATE 156 140 17 12
LOSARTAN POTASSIUM 148 128 18 22
ZETIA 146 142 19 70
DOXAZOSIN MESYLATE 135 126 20 105
DICLOFENAC SODIUM 133 112 21 103
TRAMADOL HCL 127 118 22 17
TAMSULOSIN HCL 116 96 23 29
HYDROCHLOROTHIAZIDE 116 102 23 10
SPIRIVA 114 95 25 54
DILTIAZEM ER 114 109 25 186
QUINAPRIL HCL 105 105 27 153
FAMOTIDINE 103 103 28 42
ATENOLOL 102 90 29 15
DIGOXIN 97 97 30 43
CELEBREX 96 85 31 97
SERTRALINE HCL 96 82 31 23
OXYBUTYNIN CHLORIDE 95 84 33 122
CITALOPRAM HBR 90 82 34 19
POTASSIUM CHLORIDE 89 82 35 14
PROAIR HFA 89 53 35 41
CARVEDILOL 88 58 37 21
KLOR-CON M20 85 72 38 60
ALENDRONATE SODIUM 78 70 39 20
CLOPIDOGREL 78 73 39 31
DILTIAZEM 24HR CD 74 72 41 94
JANUVIA 74 66 41 66
ADVAIR DISKUS 73 51 43 49
DONEPEZIL HCL 73 73 43 26
LOVASTATIN 71 66 45 30
GABAPENTIN 71 51 45 18
ACTOS 71 71 45 114
METFORMIN HCL 70 70 48 8
FLUTICASONE PROPIONATE 69 59 49 39
WARFARIN SODIUM 68 64 50 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 67 60 51 27
GLYBURIDE 64 60 R 52 64
PRAVASTATIN SODIUM 64 55 52 16
NEXIUM 59 56 54 37
PLAVIX 59 56 54 44
TRIAMTERENE-HCTZ 58 58 56 53
LANTUS 58 44 56 45
SINGULAIR 57 40 58 86
MELOXICAM 54 42 59 40
LEVOFLOXACIN 54 44 59 87
LANTUS SOLOSTAR 54 44 59 100
ISOSORBIDE MONONITRATE ER 53 53 62 55
AMITRIPTYLINE HCL 52 30 R 63 71
KLOR-CON 10 51 37 64 89
INSULIN SYRINGE 51 40 64 90
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.